SMAD3 and thyroid gland carcinoma: In thyroid cancer cells, oncogene activation prevented TGF-ß/SMAD-dependent p27 repression and CDK2/SMAD3 phosphorylation, leading to p65 up-regulation, which repressed BAX, induced cyclin D1 and promoted TGF-ß-dependent growth [30].